Skip to main content
. Author manuscript; available in PMC: 2016 Mar 1.
Published in final edited form as: Stroke. 2015 Jan 15;46(3):827–834. doi: 10.1161/STROKEAHA.114.007145

Figure 3.

Figure 3

ABCA1−B/−B increases WM-damage and decreases oligodendrocytes and OPCs in the ischemic brain after dMCAo. A: BS-axon (black) and LFB-myelin (blue) double-staining and quantitative data. B, C: APC and PDGFRα immunostaining and quantitative data. Scare bar in A = 40 μm, in B, C = 100 μm.